Metraipolis › archive › dc_f1bc4dc55818

Disclosure of Pharmaceutical Industry Funding of Patient Organisations in Nordic Countries: Can Industry Self-Regulation Deliver on its Transparency Promise? — Europe PMC PMID:35230175

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/35230175
DOI
10.1177/00207314221083871
License (as archived)
solo-consultazione
Archived
2026-10-08T12:35:40.833Z
SHA-256 of the archived text
c7e352d73f08657acf716ca2eb4312968385bc71be69ef5c85e3166b74b39088
Stable URL of this page
https://metraipolis.com/documento/dc_f1bc4dc55818

How to cite

Disclosure of Pharmaceutical Industry Funding of Patient Organisations in Nordic Countries: Can Industry Self-Regulation Deliver on its Transparency Promise? — Europe PMC PMID:35230175 — Europe PMC (en), https://europepmc.org/article/MED/35230175 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_f1bc4dc55818 (Metraipolis archive dc_f1bc4dc55818, sha256 c7e352d73f08657acf716ca2eb4312968385bc71be69ef5c85e3166b74b39088)
BibTeX
@misc{dcf1bc4dc55818,
  title = {Disclosure of Pharmaceutical Industry Funding of Patient Organisations in Nordic Countries: Can Industry Self-Regulation Deliver on its Transparency Promise? — Europe PMC PMID:35230175},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/35230175},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_f1bc4dc55818; sha256 c7e352d73f08657acf716ca2eb4312968385bc71be69ef5c85e3166b74b39088},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/35230175. Agents can read the archived copy with the MCP tool read_document.